Contracts › 75N93025C00040
75N93025C00040: Perform a Structure Activity Relationship (SAR), Molecular Binding and Metabolism of the Lead Scaffold (HS-176) to Guide the Development of More Potent and Drug Like Analogs, and Prioritization of Lead Analogs Through in Vitro Efficacy Screening and
Awarded to Eydis Bio, Inc. by National Institutes of Health (NIH).
$500Kobligated
$500Kpotential value
31 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93025C00040 |
|---|---|
| Awardee | Eydis Bio, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Offers received | 1 |
| Period of performance | 29 September 2025 to 31 October 2026 |
| Potential end | 31 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record